CGB logo

Cann Global Stock Price

Symbol: ASX:CGBMarket Cap: AU$5.4mCategory: Pharmaceuticals & Biotech

CGB Share Price Performance

AU$0
0.00 (0.00%)
AU$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.

CGB Community Narratives

There are no narratives available yet.

Recent CGB News & Updates

What Can We Make Of Cann Global's (ASX:CGB) CEO Compensation?

Jan 16
What Can We Make Of Cann Global's (ASX:CGB) CEO Compensation?

Cann Global Limited Key Details

AU$562.3k

Revenue

AU$640.5k

Cost of Revenue

-AU$78.2k

Gross Profit

AU$8.1m

Other Expenses

-AU$8.2m

Earnings

Last Reported Earnings
Jun 30, 2022
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.032
Gross Margin
-13.91%
Net Profit Margin
-1,461.39%
Debt/Equity Ratio
0%

Cann Global Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet medium.

5 Risks
0 Rewards

About CGB

Founded
2007
Employees
n/a
CEO
Sholom Feldman
WebsiteView website
www.canngloballimited.com

Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally. It operates through Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation segments. The company grows and cultivates hemp and medical cannabis products; provides nutritious and vitamin packed plant-based foods under the Grass Roots brand; and offers skincare products under the Fuss Pot brand. It also engages in the exploration and development of bauxite. The company was formerly known as Queensland Bauxite Limited. Cann Global Limited was incorporated in 2007 and is based in Sydney, Australia.

Market Insight

Why today’s lofty prices test investors, and how to stay invested without losing your edge.
Continue reading

Australian Market Performance

  • 7 Days: 1.0%
  • 3 Months: 3.5%
  • 1 Year: 10.9%
  • Year to Date: 7.5%
The Information Technology sector gained 3.7% while the market remained flat over the last week. More promisingly, the market is up 11% over the past year. Earnings are forecast to grow by 11% annually. Market details ›